Annual EBIT
-$45.08 M
-$10.24 M-29.40%
31 December 2023
Summary:
Corbus Pharmaceuticals Holdings annual earnings before interest & taxes is currently -$45.08 million, with the most recent change of -$10.24 million (-29.40%) on 31 December 2023. During the last 3 years, it has risen by +$77.73 million (+63.30%). CRBP annual EBIT is now -7989.97% below its all-time high of -$557.20 thousand, reached on 31 December 2013.CRBP EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$13.40 M
-$4.06 M-43.41%
30 September 2024
Summary:
Corbus Pharmaceuticals Holdings quarterly earnings before interest & taxes is currently -$13.40 million, with the most recent change of -$4.06 million (-43.41%) on 30 September 2024. Over the past year, it has dropped by -$4.33 million (-47.71%). CRBP quarterly EBIT is now -885.95% below its all-time high of $1.71 million, reached on 30 June 2019.CRBP Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$43.79 M
-$4.33 M-10.97%
30 September 2024
Summary:
Corbus Pharmaceuticals Holdings TTM earnings before interest & taxes is currently -$43.79 million, with the most recent change of -$4.33 million (-10.97%) on 30 September 2024. Over the past year, it has dropped by -$4.79 million (-12.28%). CRBP TTM EBIT is now -87137.05% below its all-time high of -$50.20 thousand, reached on 30 September 2013.CRBP TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRBP EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -29.4% | -47.7% | -12.3% |
| 3 y3 years | +63.3% | +3.4% | +34.4% |
| 5 y5 years | +20.6% | +46.6% | +35.1% |
CRBP EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -29.4% | +63.3% | -175.8% | +22.5% | -51.2% | +34.4% |
| 5 y | 5 years | -29.4% | +63.3% | -175.8% | +64.9% | -51.2% | +66.1% |
| alltime | all time | -7990.0% | +63.3% | -886.0% | +64.9% | <-9999.0% | +66.1% |
Corbus Pharmaceuticals Holdings EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$13.40 M(+43.4%) | -$43.79 M(+11.0%) |
| June 2024 | - | -$9.35 M(-2.9%) | -$39.46 M(+4.1%) |
| Mar 2024 | - | -$9.62 M(-15.8%) | -$37.90 M(-16.8%) |
| Dec 2023 | -$45.08 M(+29.4%) | -$11.42 M(+25.9%) | -$45.57 M(+16.8%) |
| Sept 2023 | - | -$9.07 M(+16.7%) | -$39.00 M(+2.2%) |
| June 2023 | - | -$7.78 M(-55.0%) | -$38.17 M(+1.2%) |
| Mar 2023 | - | -$17.30 M(+256.0%) | -$37.74 M(+30.3%) |
| Dec 2022 | -$34.84 M(-37.8%) | -$4.86 M(-41.0%) | -$28.96 M(-15.1%) |
| Sept 2022 | - | -$8.24 M(+12.3%) | -$34.10 M(-14.2%) |
| June 2022 | - | -$7.34 M(-13.8%) | -$39.73 M(-19.1%) |
| Mar 2022 | - | -$8.52 M(-14.8%) | -$49.09 M(-12.3%) |
| Dec 2021 | -$55.99 M(-54.4%) | -$10.00 M(-27.9%) | -$55.99 M(-16.2%) |
| Sept 2021 | - | -$13.88 M(-16.9%) | -$66.80 M(-23.1%) |
| June 2021 | - | -$16.70 M(+8.3%) | -$86.90 M(-19.8%) |
| Mar 2021 | - | -$15.41 M(-25.9%) | -$108.34 M(-11.8%) |
| Dec 2020 | -$122.81 M(+59.3%) | -$20.81 M(-38.7%) | -$122.81 M(-4.9%) |
| Sept 2020 | - | -$33.97 M(-10.9%) | -$129.19 M(+7.4%) |
| June 2020 | - | -$38.14 M(+27.6%) | -$120.31 M(+49.5%) |
| Mar 2020 | - | -$29.89 M(+9.9%) | -$80.47 M(+4.4%) |
| Dec 2019 | -$77.10 M | -$27.19 M(+8.3%) | -$77.10 M(+14.2%) |
| Sept 2019 | - | -$25.10 M(-1571.8%) | -$67.51 M(+17.8%) |
| June 2019 | - | $1.71 M(-106.4%) | -$57.31 M(-19.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$26.52 M(+50.8%) | -$71.41 M(+25.8%) |
| Dec 2018 | -$56.75 M(+74.3%) | -$17.59 M(+18.1%) | -$56.75 M(+13.5%) |
| Sept 2018 | - | -$14.90 M(+20.2%) | -$50.02 M(+18.9%) |
| June 2018 | - | -$12.39 M(+4.5%) | -$42.08 M(+13.8%) |
| Mar 2018 | - | -$11.87 M(+9.2%) | -$36.98 M(+13.6%) |
| Dec 2017 | -$32.56 M(+62.9%) | -$10.86 M(+56.1%) | -$32.56 M(+11.2%) |
| Sept 2017 | - | -$6.96 M(-4.6%) | -$29.27 M(+5.9%) |
| June 2017 | - | -$7.29 M(-2.2%) | -$27.65 M(+12.6%) |
| Mar 2017 | - | -$7.45 M(-1.6%) | -$24.55 M(+22.8%) |
| Dec 2016 | -$19.99 M(+125.7%) | -$7.57 M(+42.0%) | -$19.98 M(+34.0%) |
| Sept 2016 | - | -$5.33 M(+27.2%) | -$14.91 M(+26.0%) |
| June 2016 | - | -$4.19 M(+45.2%) | -$11.83 M(+16.0%) |
| Mar 2016 | - | -$2.89 M(+15.5%) | -$10.21 M(+15.3%) |
| Dec 2015 | -$8.85 M(+251.8%) | -$2.50 M(+10.9%) | -$8.85 M(+16.3%) |
| Sept 2015 | - | -$2.25 M(-12.0%) | -$7.61 M(+26.5%) |
| June 2015 | - | -$2.56 M(+67.0%) | -$6.02 M(+52.4%) |
| Mar 2015 | - | -$1.53 M(+21.9%) | -$3.95 M(+56.8%) |
| Dec 2014 | -$2.52 M(+351.6%) | -$1.26 M(+91.1%) | -$2.52 M(+64.1%) |
| Sept 2014 | - | -$659.00 K(+33.6%) | -$1.53 M(+65.9%) |
| June 2014 | - | -$493.40 K(+370.8%) | -$924.50 K(+114.5%) |
| Mar 2014 | - | -$104.80 K(-62.0%) | -$431.10 K(+32.1%) |
| Dec 2013 | -$557.20 K | -$276.10 K(+450.0%) | -$326.30 K(+550.0%) |
| Sept 2013 | - | -$50.20 K | -$50.20 K |
FAQ
- What is Corbus Pharmaceuticals Holdings annual earnings before interest & taxes?
- What is the all time high annual EBIT for Corbus Pharmaceuticals Holdings?
- What is Corbus Pharmaceuticals Holdings annual EBIT year-on-year change?
- What is Corbus Pharmaceuticals Holdings quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Corbus Pharmaceuticals Holdings?
- What is Corbus Pharmaceuticals Holdings quarterly EBIT year-on-year change?
- What is Corbus Pharmaceuticals Holdings TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Corbus Pharmaceuticals Holdings?
- What is Corbus Pharmaceuticals Holdings TTM EBIT year-on-year change?
What is Corbus Pharmaceuticals Holdings annual earnings before interest & taxes?
The current annual EBIT of CRBP is -$45.08 M
What is the all time high annual EBIT for Corbus Pharmaceuticals Holdings?
Corbus Pharmaceuticals Holdings all-time high annual earnings before interest & taxes is -$557.20 K
What is Corbus Pharmaceuticals Holdings annual EBIT year-on-year change?
Over the past year, CRBP annual earnings before interest & taxes has changed by -$10.24 M (-29.40%)
What is Corbus Pharmaceuticals Holdings quarterly earnings before interest & taxes?
The current quarterly EBIT of CRBP is -$13.40 M
What is the all time high quarterly EBIT for Corbus Pharmaceuticals Holdings?
Corbus Pharmaceuticals Holdings all-time high quarterly earnings before interest & taxes is $1.71 M
What is Corbus Pharmaceuticals Holdings quarterly EBIT year-on-year change?
Over the past year, CRBP quarterly earnings before interest & taxes has changed by -$4.33 M (-47.71%)
What is Corbus Pharmaceuticals Holdings TTM earnings before interest & taxes?
The current TTM EBIT of CRBP is -$43.79 M
What is the all time high TTM EBIT for Corbus Pharmaceuticals Holdings?
Corbus Pharmaceuticals Holdings all-time high TTM earnings before interest & taxes is -$50.20 K
What is Corbus Pharmaceuticals Holdings TTM EBIT year-on-year change?
Over the past year, CRBP TTM earnings before interest & taxes has changed by -$4.79 M (-12.28%)